Chemoinformaics analysis of 3,7-Dimethylocta-1,3,7-triene
| Molecular Weight | 136.238 | nRot | 4 |
| Heavy Atom Molecular Weight | 120.11 | nRig | 3 |
| Exact Molecular Weight | 136.125 | nRing | 0 |
| Solubility: LogS | -2.917 | nHRing | 0 |
| Solubility: LogP | 3.099 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 26 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 27.3687 |
| nHD | 0 | BPOL | 16.0513 |
| QED | 0.41 |
| Synth | 3.146 |
| Natural Product Likeliness | 2.709 |
| NR-PPAR-gamma | 0.011 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.007 |
| Pgp-sub | 0 |
| HIA | 0.002 |
| CACO-2 | -4.421 |
| MDCK | 0.0000323 |
| BBB | 0.994 |
| PPB | 0.695967 |
| VDSS | 2.282 |
| FU | 0.276428 |
| CYP1A2-inh | 0.265 |
| CYP1A2-sub | 0.792 |
| CYP2c19-inh | 0.097 |
| CYP2c19-sub | 0.903 |
| CYP2c9-inh | 0.024 |
| CYP2c9-sub | 0.861 |
| CYP2d6-inh | 0.041 |
| CYP2d6-sub | 0.911 |
| CYP3a4-inh | 0.024 |
| CYP3a4-sub | 0.246 |
| CL | 8.542 |
| T12 | 0.712 |
| hERG | 0.007 |
| Ames | 0.016 |
| ROA | 0.03 |
| SkinSen | 0.623 |
| Carcinogencity | 0.845 |
| EI | 0.992 |
| Respiratory | 0.527 |
| NR-Aromatase | 0.01 |
| Antiviral | No |
| Prediction | 0.944956 |